Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashaben Patel

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Vaccine|May 17, 2017
Combined semi-empirical screening and design of experiments (DOE) approach to identify candidate formulations of a lyophilized live attenuated tetravalent viral vaccine candidateAshaben Patel, Steven M Erb, Linda Strange, et al.
Journal of Pharmaceutical Sciences|September 4, 2018
Coformulation of Broadly Neutralizing Antibodies 3BNC117 and PGT121: Analytical Challenges During Preformulation Characterization and Storage Stability StudiesAshaben Patel, Vineet Gupta, John Hickey, et al.
Journal of Pharmaceutical Sciences|October 9, 2020
Effect of Formulation Variables on the Stability of a Live, Rotavirus (RV3-BB) Vaccine Candidate using in vitro Gastric Digestion Models to Mimic Oral DeliveryPrashant Kumar, Swathi R Pullagurla, Ashaben Patel, et al.
Human Vaccines & Immunotherapeutics|April 16, 2021
Formulation development of a live attenuated human rotavirus (RV3-BB) vaccine candidate for use in low- and middle-income countriesPrashant Kumar, Ravi S Shukla, Ashaben Patel, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Vaccine|May 17, 2017
Combined semi-empirical screening and design of experiments (DOE) approach to identify candidate formulations of a lyophilized live attenuated tetravalent viral vaccine candidateAshaben Patel, Steven M Erb, Linda Strange, et al.
Journal of Pharmaceutical Sciences|September 4, 2018
Coformulation of Broadly Neutralizing Antibodies 3BNC117 and PGT121: Analytical Challenges During Preformulation Characterization and Storage Stability StudiesAshaben Patel, Vineet Gupta, John Hickey, et al.
Journal of Pharmaceutical Sciences|October 9, 2020
Effect of Formulation Variables on the Stability of a Live, Rotavirus (RV3-BB) Vaccine Candidate using in vitro Gastric Digestion Models to Mimic Oral DeliveryPrashant Kumar, Swathi R Pullagurla, Ashaben Patel, et al.
Human Vaccines & Immunotherapeutics|April 16, 2021
Formulation development of a live attenuated human rotavirus (RV3-BB) vaccine candidate for use in low- and middle-income countriesPrashant Kumar, Ravi S Shukla, Ashaben Patel, et al.
Pageof 2